Vegan Fecal Transplants Could Lower Heart Disease Risk by Reducing TMAO

TMAO (trimethylamine N-oxide) is a toxic compound produced when gut bacteria break down nutrients found in meat, eggs, dairy, and seafood. Originally linked only to cardiovascular disease, TMAO is now associated with multiple leading causes of death including cancer, diabetes, Alzheimer's disease, and kidney disease. The compound causes inflammation, oxidative stress, DNA damage, and can even cross into the brain where it accelerates aging and cognitive decline.

Remarkably, people eating plant-based diets produce almost no TMAO even when consuming meat. This protection appears to stem from their gut microbiome composition, which lacks the bacteria that convert dietary compounds into TMAO. Even when vegans eat the equivalent of a 20-ounce steak daily for two months, they continue producing minimal TMAO levels.

This discovery has led researchers to investigate whether fecal transplants from vegan donors could help reduce TMAO production in meat-eaters. The concept builds on evidence that gut bacteria composition, rather than just diet, determines TMAO levels. Since restricting all TMAO-producing foods may be impractical for many people, altering gut bacteria through transplantation represents a potential therapeutic approach.

The implications extend beyond cardiovascular health. TMAO levels predict mortality in patients with COPD, pneumonia, and kidney disease. In chronic kidney disease patients, over half with average or higher TMAO levels died within five years, while nearly 90% with the lowest levels survived. This research highlights how our long-term dietary choices shape our gut microbiome, which in turn influences our risk for multiple chronic diseases.